| Product sales | 89.98M |
| Royalties, fees and other | 6.08M |
| Total revenues | 96.06M |
| Cost of product sales | 28.44M |
| Gross profit | 67.62M |
| Research and development | 8.03M |
| Sales and marketing | 30.53M |
| General and administrative | 14.15M |
| Amortization of intangible assets | 524K |
| Exit costs | |
| Investigation and restatement related costs | 5.19M |
| Total operating expenses | 58.42M |
| Income from operations | 9.2M |
| Foreign exchange gain (loss) | |
| Interest and other expense, net | |
| Other income and expense | -1.13M |
| Income from continuing operations before income taxes | 8.08M |
| Income tax provision | 1.86M |
| Net income from continuing operations | 6.22M |
| Income (loss) from discontinued operations | |
| Net income | |
| Accrued dividend and accretion charges on Series A 3% Redeemable Convertible Preferred Stock | -2.59M |
| Net income available to common stockholders | 3.63M |
| Basic (in shares) | 31.84M |
| Diluted (in shares) | 32.65M |
| Basic (in dollars per share) | |
| Diluted (in dollars per share) | |
| Basic (in dollars per share) | 0.11 |
| Diluted (in dollars per share) | 0.1 |